← FDA DRUG APPROVALS

FDA ANDA · ANDA074594

INDAPAMIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA074594
TYPE
ANDA
ORIGINAL APPROVAL
1996-05-23
LATEST ACTION
1997-09-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

INDAPAMIDEDiscontinued
INDAPAMIDE 2.5MG · TABLET · ORAL
INDAPAMIDEDiscontinued
INDAPAMIDE 1.25MG · TABLET · ORAL

Approval history

1997-09-05Labeling · Supplement 2AP
1996-08-27Manufacturing (CMC) · Supplement 1AP
1996-05-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →